---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-077313"
form_type: "8-K/A"
ticker: "ARMP"
cik: "0000921114"
company_name: "Armata Pharmaceuticals, Inc."
filed_at: "2026-06-24T20:19:20+00:00"
generated_at: "2026-06-24T20:20:11.536762+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Armata Pharmaceuticals appoints Dr. Daniel Gilmer to Nominating and Corporate Governance Committee

## Summary
- Dr. Daniel Gilmer appointed to the Nominating and Corporate Governance Committee effective June 24, 2026.
- Committee cash retainer set at $5,000, pro-rated from effective date.
- Amendment to April 24, 2026 8-K that reported his board appointment.

## SEC filing metadata
- accession: 0001104659-26-077313
- form_type: 8-K/A
- ticker: ARMP
- cik: 0000921114
- company_name: Armata Pharmaceuticals, Inc.
- filed_at: 2026-06-24T20:19:20+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/921114/000110465926077313/0001104659-26-077313-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/921114/000110465926077313/tm2618503d2_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-077313
- JSON: https://secwatch.observer/filing/0001104659-26-077313.json
- Plain text: https://secwatch.observer/filing/0001104659-26-077313.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.